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Amir Lerman, MD, Bruce D. Johnson, PHD, Margaret M. Redfield, MD
Rochester, Minnesota
Objectives The purpose of this study was to comprehensively examine cardiovascular reserve function with exercise in pa-
tients with heart failure and preserved ejection fraction (HFpEF).
Background Optimal exercise performance requires an integrated physiologic response, with coordinated increases in heart
rate, contractility, lusitropy, arterial vasodilation, endothelial function, and venous return. Cardiac and vascular
responses are coupled, and abnormalities in several components may interact to promote exertional intolerance
in HFpEF.
Methods Subjects with HFpEF (n  21), hypertension without heart failure (n  19), and no cardiovascular disease (con-
trol, n  10) were studied before and during exercise with characterization of cardiovascular reserve function by
Doppler echocardiography, peripheral arterial tonometry, and gas exchange.
Results Exercise capacity and tolerance were reduced in HFpEF compared with hypertensive subjects and controls, with
lower VO2 and cardiac index at peak, and more severe dyspnea and fatigue at matched low-level workloads.
Endothelial function was impaired in HFpEF and in hypertensive subjects as compared with controls. However,
blunted exercise-induced increases in chronotropy, contractility, and vasodilation were unique to HFpEF and re-
sulted in impaired dynamic ventricular-arterial coupling responses during exercise. Exercise capacity and symp-
toms of exertional intolerance were correlated with abnormalities in each component of cardiovascular reserve
function, and HFpEF subjects were more likely to display multiple abnormalities in reserve.
Conclusions HFpEF is characterized by depressed reserve capacity involving multiple domains of cardiovascular function,
which contribute in an integrated fashion to produce exercise limitation. Appreciation of the global nature of re-
serve dysfunction in HFpEF will better inform optimal design for future diagnostic and therapeutic
strategies. (J Am Coll Cardiol 2010;56:845–54) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.03.077s
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axercise intolerance is a defining symptom in patients with
eart failure and preserved ejection fraction (HFpEF), yet
ts mechanisms remain poorly understood (1). Reductionist
trategies to studying human disease are predicated on the
oncept that a single unifying process causes a specific
isease phenotype. However, HFpEF is principally a disease
f the elderly (2), and in geriatric medicine, it is more likely
hat multiple processes and age-related comorbidities coex-
st in the same patient (3). These processes interact syner-
istically to produce a clinical phenotype. Because exercise
equires coordinated changes in ventricular function, arterial
one, endothelial function, venous return, and autonomic
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uthors have reported that they have no relationships to disclose.c
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ccepted March 9, 2010.ignaling, it would be expected that abnormalities in many
uch components exist and interact to promote subjective
nd objective exercise limitation in HFpEF (4,5).
See page 864
Accordingly, the present study sought to examine multi-
le components of exercise reserve responses in patients
ith HFpEF, including assessment of chronotropic, pre-
oad, contractile, endothelial and global vascular reserve
unctions, and importantly, ventricular-arterial coupling
eserve responses. Because population-based studies have
hown that patients with HFpEF are typically older, hyper-
ensive, and female (2), and because each of these features
ay independently affect cardiovascular function, we com-
ared reserve responses in HFpEF to a predominantly
emale, elderly hypertensive control group without HF, in
ddition to an apparently healthy control group free of
ardiovascular disease.
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Study population. Subjects with
HFpEF (n  21) confirmed by
Framingham criteria (5) and EF
50% were studied in an outpa-
tient, compensated state. Exclusion
criteria included valvular or pericar-
dial disease, infiltrative or hypertro-
phic cardiomyopathy, cor pulmo-
nale, pulmonary disease, unstable
coronary disease, atrial fibrillation,
pregnancy, primary renal or hepatic
disease, and inability to exercise or to
suspend cardiovascular medicines.
Hypertensive control subjects with-
out HF (n 19, defined by history
of blood pressure140/90 mmHg
and treatment with 1 antihyper-
tensive medication) were identified
from medical chart review and con-
tacted for participation. Healthy
controls without cardiovascular dis-
ease or diabetes mellitus (n  10)
were recruited by advertisement. Be-
cause population-based studies have
shown that HFpEF patients are
predominantly older and female (2),
we sought to enroll controls with
similar demographics during screen-
ing. The study was approved by the
Mayo institutional review board.
The authors had access to and take
full responsibility for the integrity of
the data. All authors have read and
agree to the manuscript as written.
Study design. Cardiovascular
medicines were withheld for 24 h
efore study. Subjects were studied in a compensated,
asting state in a quiet, temperature-controlled room (21°C).
ransthoracic echo-Doppler/tissue Doppler study acquired
t rest and during the final 1.5 min of each 3-min graded
xercise stage (GE Vivid 7, GE Healthcare, Chalfont St.
iles, United Kingdom). Endothelial function was mea-
ured using peripheral arterial tonometry (PAT). All data
ere interpreted off-line in a blinded fashion. Heart failure
ymptoms were assessed by the Kansas City Cardiomyopa-
hy Questionnaire (KCCQ). Levels of B-type natriuretic
eptide were assessed by enzymatic immunoassay (Beck-
an Instruments, Chaska, Minnesota). Glomerular fil-
ration rate was estimated by the modified Cockroft-
ault formula. Daily dose of beta-blocker was expressed
s units of metoprolol (total daily milligrams of meto-
rolol  atenolol  2  carvedilol  4) (5). Brachial
lood pressure (BP) was obtained by auscultation by a
Abbreviations
and Acronyms
BP  blood pressure
Ea  effective arterial
elastance
Ees  end-systolic
elastance
EF  ejection fraction
HFpEF  heart failure with
preserved ejection fraction
HR  heart rate
HRR  heart rate reserve
LV  left ventricular
LVEDVI  left ventricular
end-diastolic volume index
PAT  peripheral arterial
tonometry
PRSW  pre-load
recruitable stroke work
PWRI  peak left
ventricular power index
RER  respiratory
exchange ratio
RH  reactive hyperemia
RHI  reactive hyperemia
index
SV  stroke volume
SVI  stroke volume index
SVRI  systemic vascular
resistance index
VCO2  volume carbon
dioxide produced
VE  minute ventilation
VO2  volume oxygen
consumptioningle investigator during rest and each stage of exercise. 8ean BP (diastolic pressure plus pulse pressure divided
y 3) and end-systolic BP (0.9  systolic BP) were
alculated as previously described (6).
xercise metabolic performance. Subjects underwent
aximal-effort upright cycle exercise testing starting at 20
workload, increasing by 20 W every 3 min until
xhaustion. Oxygen consumed (VO2), carbon dioxide pro-
uced (VCO2), minute ventilation (VE), and respiratory
xchange ratio (RER  VCO2/VO2) were measured
MedGraphics, St. Paul, Minnesota) throughout exercise to
uantify exercise performance (5). Subjective symptoms of
atigue and dyspnea were recorded at each workload by the
org effort score (6 to 20) and dyspnea score (0 to 10),
here higher values indicate more severe symptoms (7).
ardiovascular function and reserve analysis. Echo-
oppler measurements represent the mean of 3 beats.
he left ventricular (LV) mass was obtained from
-dimensional measurements of wall thickness and chamber
imension (8). The EF was determined from Simpson’s
iplane method (8). Stroke volume (SV) was determined
rom the LV outflow dimension and pulse-wave Doppler
nd was indexed to body surface area (SVI). Cardiac index
as determined from the product of heart rate (HR) and
VI.
HRONOTROPIC RESERVE. Heart rate reserve (HRR) was
etermined from continuous 12-lead electrocardiogram us-
ng standard formulas, with chronotropic incompetence is
efined as HRR 0.8, or HRR 0.62 in subjects receiving
eta-adrenergic antagonists (9).
RE-LOAD AND PRE-LOAD RESERVE. The left ventricular
nd-diastolic volume index (LVEDVI) was determined
rom the quotient of SVI/EF (8,10). Resting transmitral
ow velocities (E and A) and mitral annular tissue-Doppler
elocities (E= and A=) were measured to assess diastolic
unction. The E/E= ratio was used to estimate filling
ressures at rest (8). Doppler estimation of filling pressures
ith exercise was not performed.
ONTRACTILE FUNCTION AND RESERVE. Load-independent
ontractility was determined using 3 separate indexes: 1)
eak power index (PWRI [determined from product of
eak volumetric ejection rate from LV outflow Doppler
nd systolic BP, divided by EDV]) (10,11); 2) single-beat
nd-systolic elastance (Ees [determined from BP, SV, EF,
nd pre-ejection and systolic ejection time intervals from
V outflow Doppler]) (12); and 3) single-beat pre-load
ecruitable stroke work (PRSW [determined from SV,
ean BP, LV mass, and EDV]) (13). The change in each
arameter was used to characterize contractile reserve.
ASCULAR FUNCTION AND RESERVE. Ventricular afterload
as measured by systemic vascular resistance (mean BP 
0/CO) and effective arterial elastance (Ea  ESP/SV)
(
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September 7, 2010:845–54 Cardiovascular Reserve Dysfunction in HFpEF6,8) at rest, with the change in each during exercise used to
haracterize global arterial reserve.
NDOTHELIAL FUNCTION. The PAT was measured using
he EndoPAT 2000 system (Itamar-Medical, Caesarea,
srael). Endothelial function was quantified by the reactive
yperemic (RH) change in digital blood flow after arm
cclusion (14,15). After 5 min of baseline recording, a BP
uff was inflated to supra-systolic pressure in the test arm.
fter 5 min of occlusion, the cuff was rapidly deflated, with
AT tracings recorded. The RH-PAT response was deter-
ined as the ratio of PAT amplitude in the test arm to
ontrol arm, averaged in 30-s intervals after cuff deflation,
ivided by the average PAT ratio measured for the 140-s
nterval before cuff inflation. The reactive hyperemia index
RHI) was determined as the RH-PAT ratio measured
etween 60 s and 120 s after occlusion. Endothelial dys-
unction was defined categorically by RHI 2.0. The RHI
as log-transformed for subsequent analysis (14).
Dynamic peripheral vasodilation was further assessed by
hanges in PAT amplitude responses during exercise (16).
ean PAT amplitudes were determined from 3 min re-
ordings obtained at rest and at peak exercise after manually
eleting motion artifacts. Exercise PAT responses were
ormalized to baseline PAT amplitude to create a dimen-
ionless unit, and represent the average of both arms.
ENTRICULAR-VASCULAR COUPLING AND COUPLING
ESERVE. Ventricular-arterial interaction was assessed by
he coupling ratio (Ea/Ees) of arterial to ventricular systolic
lastance (6).
tatistical analysis. Continuous variables are reported as
ean  SD. Between-group differences were compared
y chi square, 1-way analysis of variance, or Wilcoxon
ank-sum/Kruskal-Wallis tests. Normality was evaluated
y the Shapiro-Wilk W test. Bonferroni correction was
pplied for multiple comparisons. The hyperemic changes
n PAT amplitude between groups were compared by
epeated measures analysis of variance assuming a quadratic
elationship of PAT ratio over time. Linear regression was
erformed to test associations between reserve function,
ymptoms and exercise performance.
esults
ubject characteristics. Age, sex, race (all but 2 Cauca-
ian), and renal function were similar in all groups, with
ontrols and HFpEF being more obese than hypertensive
ubjects (Table 1). Coronary disease and diabetes mellitus
ere more common in HFpEF subjects. The B-type natri-
retic peptide levels were higher and KCCQ scores lower
more symptomatic) with HFpEF. The HFpEF subjects
ere more likely to be receiving loop diuretics and lipid-
owering therapy. Other medication use was similar in
FpEF subjects and hypertensive subjects, including beta-
lockers and mean dose of beta-blockers (not shown). testing cardiovascular function. The HR, BP, LVEDVI,
ontractility, ventricular-arterial coupling, and cardiac index
ere similar across groups at rest (Table 1). The E/E= was
igher in HFpEF subjects, consistent with diastolic dys-
unction. Global vascular function (Ea and SVRI) was not
ifferent between groups. However, the hyperemic increase
n PAT amplitude after cuff occlusion was blunted in
FpEF and hypertensive subjects compared with controls,
onsistent with depressed endothelium-dependent vasodi-
ation (Fig. 1). Mean RHI was lower in HFpEF and
ypertensive subjects compared with controls, but similar in
FpEF and hypertensive subjects (Table 1). The prevalence
f endothelial dysfunction was 42% in HFpEF subjects
p  0.05 vs. control; p  NS vs. hypertension), 28% in
ypertensive subjects (p  0.056 vs. control), and 0% in
ontrols.
xercise performance. Exercise time, peak workload, VO2
t ventilatory threshold, peak VO2, and percent predicted
eak VO2 were all impaired in HFpEF subjects compared
ith control and hypertensive subjects, whereas the latter
roups were similar (Table 2). Borg effort and dyspnea
cores in HFpEF were higher at matched submaximal
orkload (20 W), indicating greater perceived difficulty
ith exercise. At peak, Borg scores were similar in HFpEF
ubjects, hypertensive subjects, and controls, consistent with
aximal subjective effort in all groups. Peak RER tended to
e lower in HFpEF subjects, though excluding the subjects
ho failed to attain a peak RER 1.0 did not affect the
ifferences observed in any parameters (not shown).
eserve responses at matched low-level (20 W) exercise.
HRONOTROPIC RESERVE. HR increased in HFpEF sub-
ects (23  6 beats/min, p  0.0001), hypertensive
ubjects (23  10 beats/min, p  0.0001), and controls
26  8 beats/min, p  0.0001), with no between-group
ifference (p  0.2).
RE-LOAD RESERVE. The LVEDVI increased in HFpEF
ubjects (6  9 ml/m2), hypertensive subjects (5  7
l/m2), and controls (11  9 ml/m2; p  0.0001 for all),
ith no between-group difference (p  0.2).
ONTRACTILE RESERVE. The increase in contractility as-
essed by Ees, PRSW, and PWRI was 65% to 85% lower in
FpEF subjects compared with hypertensive and normal
ontrols (Fig. 2). The LVESVI failed to drop in HFpEF
ubjects (2  7 ml/m2) in comparison with hypertensive
nd healthy controls (6  5 ml/m2 and 5  5 ml/m2,
espectively; both p  0.05 compared with HFpEF subjects).
ASCULAR FUNCTION AND RESERVE. Vasodilation was at-
enuated in HFpEF subjects, with less reduction in SVRI and
a compared with hypertensive and normal controls (Fig. 2).
ENTRICULAR VASCULAR COUPLING RESERVE. The combi-
ation of blunted increases in contractility and impaired
asodilation in HFpEF patients was associated with im-
aired ventricular-arterial coupling, with less reduction in
he Ea/Ees ratio (Fig. 2) and less increase EF (0  8%
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ypertensive subjects, p  0.0001). Augmentation in car-
iac index at 20W was lower in HFpEF subjects (1.1 
.4 l/min  m2) than in controls (2.2  0.9 l/min  m2,
 0.001) and hypertensive subjects (vs. 1.8  0.7
/min  m2, p  0.002).
eserve responses at peak exercise. CHRONOTROPIC
ESERVE. Peak HR was reduced in HFpEF subjects compared
ith both control and hypertensive subjects (Table 3). The HRR
as lower in HFpEF subjects (56  17%) compared with
ypertensive subjects (79 20%, p 0.001) and controls (93
7%, p  0.0001), even after adjusting for chronic beta-blocker
se. Among HFpEF subjects with peak RER 1.0, the preva-
Clinical Characteristics and Resting CardiovascTable 1 Clinical Characteristics and Resting
Control
(n  10)
Clinical characteristics
Age, yrs 62 7
Sex, female 70
Body mass index, kg/m2 31.2 7.9
KCCQ score 99 4
Hypertension 0
Coronary artery disease 0
Diabetes mellitus 0
Smoking 0
GFR, ml/min 87 17
Plasma BNP, pg/ml 38 40
Hemoglobin, g/dl 13.0 2.2
Beta-blockers 0
ACEI or ARB 0
Loop diuretic 0
Lipid lowering 40
LV mass index, mg/m2 68.2 19.8
Resting function
Heart rate, beats/min 70 8
Pre-load
LVEDVI, ml/m2 54 8
E/E= ratio 12 4
Contractility
PWRI, mm Hg/s 330 80
PRSW, g/cm2 79 19
Ees, mm Hg/ml 1.48 0.38
Vascular function
Systolic BP, mm Hg 123 16
Ea, mm Hg/ml 1.88 0.40
SVRI, dyne·m2/s·cm5 3,430 920
Log RHI 1.33 0.34
Endothelial dysfunction 0
Ventricular arterial coupling
Coupling ratio, Ea/Ees 1.32 0.34
Ejection fraction, % 58 7
Cardiac index, l/min·m2 2.2 0.5
Values are mean  SD or %. Final column reflects overall group analys
0.05 versus hypertension; †p  0.05 versus control (ANOVA after B
ACEI  angiotensin-converting enzyme inhibitors; ARB  angiotens
Ea arterial elastance; Ees left ventricular end-systolic elastance; G
fraction; KCCQ Kansas City Cardiomyopathy Questionnaire; LVEDVI
recruitable stroke work; PWRI  peak left ventricular power index; RHence of chronotropic incompetence was 57%. sRE-LOAD RESERVE. The EDVI tended to increase more in
ontrols, but this was not significant (p  0.2).
ONTRACTILE RESERVE. Increases in contractility at peak
xercise were 65% lower in HFpEF subjects compared
ith hypertensive subjects and controls for each load-
ndependent measure (p  0.001). Peak exercise reduction
n ESVI was impaired in HFpEF subjects.
ASCULAR RESERVE. Exercise reduction in SVRI and aug-
entation in peripheral blood flow (PAT amplitude) were
oth blunted in HFpEF subjects compared with hyperten-
ive subjects and controls, although the changes in Ea were
unctiondiovascular Function
Hypertension
(n  19)
HFpEF
(n  21) p Value
65 11 67 11 0.4
74 76 0.9
28.3 3.0 34.3 6.6* 0.004
94 16 69 18*† 0.001
100† 86† 0.001
11 33† 0.02
5 43*† 0.003
0 9 0.2
81 20 81 38 0.9
60 50 152 106*† 0.001
14.2 1.5 13.0 1.3 0.06
42† 57† 0.001
53† 67† 0.001
0 57*† 0.001
63 90† 0.009
90.7 21.8 88.0 27.1 0.05
71 12 68 12 0.9
59 12 58 19 0.6
12 5 20 7*† 0.003
348 59 339 69 0.8
77 19 81 40 0.9
1.72 0.38 1.79 0.76 0.4
136 12 131 21 0.2
1.97 0.51 1.77 0.62 0.3
,430 750 3,100 880 0.4
0.92 0.38† 0.85 0.42† 0.009
28 42† 0.016
1.16 0.24 1.08 0.35 0.2
58 5 60 6 0.5
2.4 0.6 2.3 0.6 0.7
riance (ANOVA) or chi square. For between-group comparisons: *p 
oni).
tor blockers; BNP  B-type natriuretic peptide; BP  blood pressure;
omerular filtration rate; HFpEF heart failure with preserved ejection
ntricular end-diastolic volume index; PRSW left ventricular pre-load
ctive hyperemia index; SVRI  systemic vascular resistance index.ular FCar
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nd vascular reserve impairments produced abnormal dy-
amic ventricular-arterial coupling responses at peak exer-
ise in HFpEF subjects, with less reduction in the Ea/Ees
atio and less increase in EF and cardiac index. Reflecting
he potent differences in contractile reserve function, systolic
P increased less in HFpEF subjects (34  25 mm Hg)
han in hypertensive subjects (56  23 mm Hg, p  0.05)
r healthy controls (76  28 mm Hg, p  0.05).
mpact of coronary disease. No subject displayed ischemic
lectrocardiographic or wall motion changes during exercise.
fter adjusting for history of coronary disease, all differences
n endothelial function and ventricular-vascular reserve re-
ained significant (not shown). Subgroup analysis restricted
o only subjects without history of coronary disease showed
imilar impairments in low-level and peak contractile reserve
n HFpEF subjects, with the exception of the increase in Ees
t 20W, which was no longer significant (not shown). Among
30 60 90 120 150 180 210 240
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HFpEF vs Control p=0.002
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Figure 1 Assessment of Endothelial Function
(A) Increases in peripheral arterial tonometry (PAT) amplitude with reactive hypere
(red line) and hypertensive subjects (green line) compared with control subjects (
(log RHI) is reduced in HFpEF subjects (red bar) and hypertensive subjects (green
tion (orange area) was more prevalent in HFpEF subjects (42%, p  0.05) and ten
bars indicates normal. p  0.05 HFpEF versus control; †p  0.05 hypertension v
Exercise PerformanceTable 2 Exercise Performance
Control
(n  10)
Exercise time, s 831 230
Peak workload, W 96 25
Respiratory exchange ratio 1.09 0.07
VO2 at VAT, cc/kg/min 14.6 2.7
Peak VO2, cc/kg/min 18.6 3.3
Percent predicted peak VO2, % 87 22
VE/VCO2 slope 34.0 2.9
20 W Borg effort, 6–20 8.6 1.6
20 W Borg dyspnea, 0–10 0.9 0.7
Peak Borg effort, 6–20 16.4 1.6
Peak Borg dyspnea, 0–10 5.4 2.2
Final column reflects overall group ANOVA or chi square. For between-g
(ANOVA after Bonferroni).VAT  ventilatory anaerobic threshold; VCO2  carbon dioxide production
abbreviations as in Table 1.ubjects without coronary disease, the prevalence of endothelial
ysfunction was 0% in controls, 31% in HFpEF subjects, and
1% in hypertensive subjects (each p  0.02 compared with
ontrol). In this subgroup, log RHI tended to be lower in
FpEF subjects compared with control (0.96  0.42 vs. 1.33
0.34), although this difference was no longer significant (p
.09 after Bonferroni).
lobal reserve dysfunction and exercise intolerance in
FpEF. Several indexes of cardiovascular reserve function
ncluding chronotropic (	HR), contractile (	PWRI), vas-
ular (	SVRI, 	PAT), endothelial (log RHI), and
entricular-arterial (	Ea/Ees) coupling responses were each
ignificantly associated with peak VO2 (Table 4). The
umber of individual reserve abnormalities (defined as
25th percentile values observed in the healthy controls)
ere tabulated for each subject. The HFpEF patients had
he greatest number of abnormalities (Fig. 3A), and the
resence of more reserve abnormalities was associated with
p=0.016
CON HTN HFpEF
0
50
100
%
 o
f s
ub
jec
ts
C
Endothelial DysfunctionNormal
HFpEF
*
N
e diminished in heart failure with preserved ejection fraction (HFpEF) patients
ne), consistent with endothelial dysfunction. (B) Mean reactive hyperemia index
ompared with control (blue bar). (C) Compared with control, endothelial dysfunc-
be more common in hypertensive subjects (28%, p  0.056). Green area of
control. CON  control; HTN  hypertension.
ypertension
(n  19)
HFpEF
(n  10) p Value
801 314 497 214*† 0.0005
91 27 55 23*† 0.0001
1.09 0.08 1.02 0.09 0.02
13.8 2.6 10.4 2.3*† 0.0001
18.1 3.5 12.7 3.1*† 0.0001
93 24 57 18*† 0.0001
34.1 4.0 35.6 5.0 0.7
9.2 1.7 11.1 2.0*† 0.003
1.0 0.9 2.6 1.6*† 0.0009
16.1 1.8 15.7 2.2 0.7
5.1 1.8 4.5 2.0 0.9
mparisons: *p 0.05 versus control; †p 0.05 versus hypertensionHT
†
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Cardiovascular Reserve Dysfunction in HFpEF September 7, 2010:845–54rogressively more depressed exercise capacity (Fig. 3B). Of
ote, several indices of cardiovascular reserve function also
orrelated with subjective dyspnea and fatigue at matched
ow-level workload (Table 4).
iscussion
his study found evidence for global impairment in cardio-
ascular reserve function in HFpEF subjects compared with
ormal and hypertensive controls, including limitations in
hronotropic, contractile, endothelial, and vascular reserve,
esulting in markedly impaired ventricular-arterial coupling
esponses to exercise. Depressed reserve responses correlated
ith reduced exercise capacity and greater subjective symp-
oms at low-level workload, and the accumulation of more
ndividual abnormalities was associated with progressively
reater impairment in exercise capacity. These data confirm
nd extend upon a growing body of evidence demonstrating
hat the pathophysiology of HFpEF is complex and char-
cterized by global impairment in multiple domains of
ardiovascular reserve function.
ontractile reserve. Patients with HFpEF have a “nor-
al” ejection fraction, but EF is a rather poor measure of
ontractility because of its sensitivity to load and chamber
emodeling (17,18). To accurately assess contractility, pre-
oad and afterload must both be accounted for (19). Using
oad-independent measures, we observed that contractile
eserve responses with exercise were blunted in HFpEF
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Figure 2 Contractile, Vascular, and Coupling Reserve With Low
(A to C) Compared with both control subjects (blue bars) and hypertensive subjec
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ther words, are observed deficits in contractile reserve in
FpEF subjects a mechanism or consequence of exercise
imitation?
The current study resolves this question by demonstrating
hat at matched, low-level workload (20 W), contractile
eserve is impaired in HFpEF. In an earlier study, we found
notropic reserve impairments in HFpEF subjects compared
ith hypertensive subjects at peak but not at low-level
xercise (5). However, the hypertensive control group in the
atter study had more severe limitation (peak VO2 70%
redicted) and more abnormal ventricular remodeling
90% with LV hypertrophy). The current findings are
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uced tissue-Doppler systolic shortening velocities and
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ay be affected by abnormalities in energy substrate bio-
vailability, as has recently been demonstrated in HFpEF
21,24).
ndothelial function and vasodilator reserve. Investiga-
ors first noted endothelial dysfunction in patients with
Cardiovascular Reserve Responses at Peak ExeTable 3 Cardiovascular Reserve Responses
Control
(n  10)
Chronotropic reserve
	HR 82 21
Pre-load reserve
	LV EDVI, ml/m2 13 15
Contractile reserve
	PWRI, mm Hg/s 471 179
	PRSW, g/cm2 112 53
	Ees, mm Hg/ml 2.87 1.52
	LV ESVI, ml/m2 5 7
Vascular reserve
	Ea, mm Hg/ml 0.19 0.62
	SVRI, dyne·m2/s·cm5 2,070 730
	digital PAT amplitude 2.52 0.99
Coupling reserve
	coupling ratio, Ea/Ees 0.93 0.22
	ejection fraction, % 16 8
	CI, l/min·m2 5.1 2.2
Final column reflects overall group ANOVA or chi square. For between-g
(ANOVA after Bonferroni).
CI  cardiac index; 	  peak change; EDVI  end-diastolic vol
abbreviations as in Table 1.
elationships Between Reserve andak Exercise Capacity or Symptoms atatched Low-Level Workload (20 W)
Table 4
Rela ionships Between Reserve and
Peak Exercise Capacity or Symptoms at
Matched Low-Level Workload (20 W)
Pearson r p Value
Peak volume oxygen consumption
Chronotropic reserve, 	HR 0.70 0.0001
Contractile reserve, 	PWRI 0.73 0.0001
Endothelial function, log RHI 0.43 0.003
Vascular reserve, 	SVRI 0.40 0.009
Vascular reserve, 	 log PAT 0.52 0.0007
Coupling reserve, 	Ea/Ees 0.51 0.0006
20 W Borg fatigue
Chronotropic reserve, 	HR 0.37 0.007
Contractile reserve, 	PWRI 0.44 0.004
Endothelial function, log RHI 0.52 0.0002
Vascular reserve, 	SVRI 0.37 0.02
Vascular reserve, 	 log PAT 0.47 0.003
Coupling reserve, 	Ea/Ees 0.52 0.0006
20 W Borg dyspnea
Chronotropic reserve, 	HR 0.48 0.0005
Contractile reserve, 	PWRI 0.61 0.0001
Endothelial function, log RHI 0.39 0.007
Vascular reserve, 	SVRI 0.37 0.02
Vascular reserve, 	 log PAT 0.32 0.052
Coupling reserve, 	Ea/Ees 0.49 0.001dbbreviations as in Tables 1 and 3.eart failure and reduced ejection fraction (HFrEF) in the
arly 1990s (25,26), and recent work has suggested that this
ay contribute to symptoms of breathlessness and fatigue
y enhancing abnormal skeletal muscle signaling during
xercise (27). However, few studies have examined endo-
helial function in HFpEF subjects.
Hundley et al. (28) measured exercise capacity and
ow-mediated arterial dilation in the femoral artery by
agnetic resonance imaging in 9 subjects with HFpEF,
omparing them to 11 normal controls and 10 HFrEF
ubjects. Exercise capacity was reduced in both HFrEF and
FpEF, but flow-mediated arterial dilation was impaired
nly in HFrEF. However, flow-mediated vasodilation in
arge conduit arteries (e.g., femoral) may differ from that
bserved in the microvasculature (as in the current study).
e now show for the first time that endothelial function is
mpaired in HFpEF subjects compared with apparently
ealthy controls, assessed at the microvasculature. Part of
his deficit may be related to atherosclerosis, though RHI
emained lower in HFpEF subjects after adjusting for
oronary disease, and mean RHI values were similar in
FpEF patients with or without coronary disease. Hyper-
ensive subjects also displayed endothelial dysfunction, but
ad preserved exercise capacity, possibly related to preser-
ation of other components of reserve function. Endothelial
ysfunction correlated with reduced exercise capacity and
reater symptoms, suggesting a role in contributing to
bjective and subjective exertional intolerance in HFpEF.
During normal exercise, arterial resistance decreases to
ccommodate large increases in flow with minimal incre-
ent in pressure (6). Prior studies have demonstrated using
ak Exercise
ertension
n  19)
HFpEF
(n  21) p Value
65 15 47 17*† 0.0001
7 10 5 9 0.2
391 119 139 103*† 0.0001
93 54 27 23*† 0.0001
.18 0.94 0.88 0.82*† 0.0002
7 6 1 9† 0.004
.07 0.42 0.22 0.37 0.16
890 610 1,110 530*† 0.0006
.33 1.38 1.46 0.77* 0.027
.67 0.24 0.21 0.39*† 0.0001
16 7 3 7*† 0.0001
4.1 1.1 2.2 1.1*† 0.0001
mparisons: *p 0.05 versus control; †p 0.05 versus hypertension
dex; HR  heart rate; PAT  peripheral arterial tonometry; otherrciseat Pe
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urrent findings confirm these studies using the same
erived vascular measures, and importantly, extend upon
hem by demonstrating for the first time that directly
easured peripheral vasodilation (change in digital PAT
mplitude with exercise) is also depressed in HFpEF.
entricular-arterial interaction with exercise. Abnormal
asorelaxation, combined with blunted contractile reserve,
ed to abnormal ventricular-arterial coupling in HFpEF. In
he pressure-volume plane, contractility is expressed by
nd-systolic elastance (Ees), defined by the slope and
ntercept of the end systolic pressure-volume relationship,
hile afterload is defined by effective arterial elastance (Ea),
lumped parameter incorporating both mean and pulsatile
ascular load (6). Ventricular-arterial interaction is de-
cribed by the coupling ratio (Ea/Ees). Under normal
ircumstances, Ea/Ees drops with exercise, because the
ncrease in Ees exceeds the change in Ea, leading to an
ncrease in EF (6). The normal exercise drop in Ea/Ees
ecomes impaired with aging (29), and Phan et al. (21)
ecently found that the drop in the ratio of end-systolic
olume to stroke volume (which is related to Ea/Ees) was
mpaired in HFpEF subjects compared with hypertensive
ubjects at 50% maximal effort (21). The current findings
onfirm and extend upon the latter, showing that abnormal
entricular-arterial coupling is present both at matched,
bjective low-level workload and throughout exercise in
FpEF subjects compared with hypertensive subjects and
ormal controls.
hronotropic reserve. The current data confirm previ-
usly reported impairment in peak chronotropic reserve and
ts relationship to exercise limitation (5,21). Heart rate
eserve was lower in the HFpEF patients, and more than
alf met criteria for chronotropic incompetence (9). In
ontrast to an earlier study (5) and to contractile and
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Figure 3 Global Reserve Dysfunction
(A) Heart failure with preserved ejection fraction (HFpEF) subjects displayed a grea
(HTN) subjects and normal controls (CON), and hypertensive subjects had more ab
greater number of reserve abnormalities was associated with more severely depre
each grouping for control subjects (blue), hypertensive subjects (green), and HFpE
relationship of number of abnormalities versus peak VO2.ascular reserves in this study, HR responses were not vlunted at submaximal workload in HFpEF, making it
ifficult to discern whether chronotropic incompetence
ontributed to exercise limitation in HFpEF or was simply
elated to the lower peak workload achieved.
re-load reserve. While diastolic dysfunction was present
t rest, exercise changes in diastolic compliance and relax-
tion were not assessed in this study. Kitzman et al. (30)
ound that EDVI failed to increase with exercise in HFpEF
atients compared with controls, whereas in the current
tudy and in an earlier report (5), EDVI increased by 5% to
0% in HFpEF subjects during exercise. However, nearly
ne-half of the patients in the Kitzman study had either
nfiltrative or hypertropic cardiomyopathy, diseases known
o produce the most extreme forms of diastolic dysfunction.
hese patients were excluded from the latter analyses, and
hat may explain the apparent discrepancies in pre-load
eserve. We observed a trend toward greater EDVI reserve
n healthy controls at peak exercise compared with HFpEF
ubjects and hypertensive subjects, and the absence of a
ignificant difference may be related to the small sample size
n the healthy controls. Finally, changes in filling pressures
ith exercise, which are known to be abnormal in HFpEF
ubjects (30,31), were not assessed in this study, and therefore
he current results should not be interpreted as minimizing the
mportance of diastolic reserve in HFpEF (30).
linical implications. Because diastolic dysfunction is
eadily detectable in most HFpEF patients and plausibly
xplains many symptoms, it has traditionally been concep-
ualized as the sole or predominant mechanism. This
athophysiologic model is similar to other disorders where a
ingle lesion (e.g., cortisol excess) produces a wide variety of
linical sequelae (bone loss, hypertension, glucose intoler-
nce). Our data show that rather than being a disease of
iastolic dysfunction alone, HFpEF is characterized by a
umber of abnormalities in endothelial and ventricular-
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pidemiology studies suggest that HFpEF is not due to
systemic disease, but rather, in the majority of cases,
epresents a culmination of a number of different disease
rocesses associated with aging, hypertension, and diabetes
ellitus. Understanding the pleiotropic nature of reserve
imitation of HFpEF may allow for more focused and
ailored therapies for individual patients, and it is hoped that
uture research will identify the specific mechanistic pro-
esses that produce global reserve dysfunction in HFpEF.
tudy limitations. This is a cross-sectional study and
annot assess causality. Pressure and flow were not directly
easured, but rather estimated from noninvasive surrogates.
hile these derived parameters have been validated in
rior studies against invasive hemodynamic measurements
10–13), there is inherently greater variability compared
ith the gold standard measures. Because of image fore-
hortening during exercise, EDVI was determined from SV
nd EF rather than from 2-dimensional imaging alone.
his assumes that mitral regurgitation, which was not
easured directly, was not significant.
onclusions
eart failure is often conceptualized as being caused by
solated, discrete disease mechanisms, such as diastolic or
ystolic dysfunction. However, HFpEF is a disease of the
lderly, and with aging, patients acquire multiple comor-
idities and processes that integrate in complex ways to
roduce symptoms and exercise intolerance. The current
esults, taken in concert with other recent studies, suggest
hat in most cases, HFpEF is not simply the result of a
ingle impairment in 1 component of cardiovascular func-
ion, but rather a culmination of global limitations of
ardiovascular reserve function—chronotropy, inotropy,
usitropy and vasodilation—all resulting in impaired ven-
ricular arterial coupling, depressed cardiac output response,
nd subjective and objective exercise intolerance. Recogni-
ion that reserve dysfunction in HFpEF is a global process
ffecting many cardiovascular responses to stress will aid in
he design and testing of future therapeutic strategies for
FpEF.
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